| K-number | K233364 |
| Device name | Axon Therapy |
| Applicant | Neuralace Medical, Inc. |
| Product code | QPL |
| Device class | Class II |
| Decision date | Jan 10, 2024 |
| Decision | Substantially Equivalent |
| Regulation | 882.5890 |
AI extraction for this record is queued and will appear within 24 hours. View full FDA record →
View the full FDA submission: accessdata.fda.gov